These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3915155)

  • 21. Pharmacokinetics of mefloquine alone or in combination with artesunate.
    Karbwang J; Na Bangchang K; Thanavibul A; Back DJ; Bunnag D; Harinasuta T
    Bull World Health Organ; 1994; 72(1):83-7. PubMed ID: 8131255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmodium falciparum-malaria: resistance to chloroquine, but sensitivity to mefloquine in the Gabon. A prospective in-vitro study.
    Burchard GD; Horstmann RD; Wernsdorfer WH; Dietrich M
    Tropenmed Parasitol; 1984 Mar; 35(1):1-4. PubMed ID: 6369691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacy of chloroquine and cotrimoxazole in the treatment of acute uncomplicated falciparum malaria in Nigerian children.
    Fehintola FA; Adedeji AA; Sowunmi A
    Cent Afr J Med; 2002; 48(9-10):101-5. PubMed ID: 14562530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of the amodiaquine+sulfadoxine-pyrimethamine combination and of chloroquine for the treatment of malaria in Córdoba, Colombia, 2006].
    Pérez MA; Cortés LJ; Guerra AP; Knudson A; Usta C; Nicholls RS
    Biomedica; 2008 Mar; 28(1):148-59. PubMed ID: 18645670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
    Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
    Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
    Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India.
    Dunne MW; Singh N; Shukla M; Valecha N; Bhattacharyya PC; Patel K; Mohapatra MK; Lakhani J; Devi CU; Adak T; Dev V; Yadav RS; Lele C; Patki K
    Am J Trop Med Hyg; 2005 Dec; 73(6):1108-11. PubMed ID: 16354821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru.
    Marquiño W; MacArthur JR; Barat LM; Oblitas FE; Arrunátegui M; Garavito G; Chafloque ML; Pardavé B; Gutierrez S; Arróspide N; Carrillo C; Cabezas C; Ruebush TK
    Am J Trop Med Hyg; 2003 Jan; 68(1):120-3. PubMed ID: 12557836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand.
    Walsh DS; Looareesuwan S; Wilairatana P; Heppner DG; Tang DB; Brewer TG; Chokejindachai W; Viriyavejakul P; Kyle DE; Milhous WK; Schuster BG; Horton J; Braitman DJ; Brueckner RP
    J Infect Dis; 1999 Oct; 180(4):1282-7. PubMed ID: 10479159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study.
    Valecha N; Savargaonkar D; Srivastava B; Rao BH; Tripathi SK; Gogtay N; Kochar SK; Kumar NB; Rajadhyaksha GC; Lakhani JD; Solanki BB; Jalali RK; Arora S; Roy A; Saha N; Iyer SS; Sharma P; Anvikar AR
    Malar J; 2016 Jan; 15():42. PubMed ID: 26818020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical manifestations of Plasmodium vivax malaria.
    Mohapatra MK; Padhiary KN; Mishra DP; Sethy G
    Indian J Malariol; 2002; 39(1-2):18-25. PubMed ID: 14686106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clinical trial of mefloquine in the treatment of Plasmodium vivax malaria.
    Dixon KE; Pitaktong U; Phintuyothin P
    Am J Trop Med Hyg; 1985 May; 34(3):435-7. PubMed ID: 3890575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimalarial activity of mefloquine and chloroquine against blood induced Plasmodium knowlesi infection in rhesus monkeys.
    Singh PP; Dutta GP
    Indian J Med Res; 1981 Jan; 73 Suppl():23-8. PubMed ID: 6974694
    [No Abstract]   [Full Text] [Related]  

  • 36. Ketotifen in treatment of uncomplicated falciparum malaria.
    Ibrahim AM; Elhag ER; Mustafa SE
    Saudi Med J; 2000 Mar; 21(3):257-65. PubMed ID: 11533794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vivo susceptibility of Plasmodium falciparum to cholorquine in pregnant and non-pregnant women and in-vitro response of P. falciparum to chloroquine and mefloquine in Madang Province, Papua New Guinea.
    Klever HJ; Witte AM; Brabin BJ; Eggelte T; van der Kaay HJ; Alpers MP
    Acta Leiden; 1988; 57(1):29-38. PubMed ID: 3072818
    [No Abstract]   [Full Text] [Related]  

  • 38. A randomized trial comparing the efficacy of four treatment regimens for uncomplicated falciparum malaria in Assam state, India.
    Campbell P; Baruah S; Narain K; Rogers CC
    Trans R Soc Trop Med Hyg; 2006 Feb; 100(2):108-18. PubMed ID: 16289651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous opioids, mu-opiate receptors and chloroquine-induced pruritus: a double-blind comparison of naltrexone and promethazine in patients with malaria fever who have an established history of generalized chloroquine-induced itching.
    Ajayi AA; Kolawole BA; Udoh SJ
    Int J Dermatol; 2004 Dec; 43(12):972-7. PubMed ID: 15569037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
    Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
    Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.